For instance, many clinical laboratories routinely use tumor gene panels, primarily for solid tumors, which almost invariably include the KRAS gene, enabling the incorporation of detection of individual gene alterations also from the ETV6::RUNX1 ALL samples to diagnostic workflow. This evidence concerns the gene RUNX1 and acute lymphoblastic leukemia.